January 31, 2017
Neurosurgeons from Germany and U.S.A. report on their clinical experience of using Nexstim NBS system
Media
January 31, 2017
Radiotherapy, immunotherapy and DNA repair inhibitors: a winning combination towards the oncology of the future
January 31, 2017
GenSight Biologics receives FDA Orphan Drug Designation for GS030 in Retinitis Pigmentosa
January 27, 2017
GenSight Biologics reports its cash position as of December 31, 2016
January 24, 2017
Onxeo Completes Enrollment in Phase III Study of Livatag® for the Treatment of Hepatocellular Carcinoma
January 19, 2017
PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases
January 19, 2017
Clinical progress, cash position and revenue for Q4 2016
January 11, 2017
Nexstim Plc announces signing of an Independent Selling Representative Agreements in U.S.
January 09, 2017
Strongbridge Biopharma plc Expands Commercial Capabilities with Two Rare Disease Executive Hires
January 05, 2017
Targovax announces appointment of Erik Digman Wiklund as CFO